By: Huffman  S.B. No. 172
         (In the Senate - Filed November 10, 2014; January 27, 2015,
  read first time and referred to Committee on Criminal Justice;
  March 16, 2015, reported adversely, with favorable Committee
  Substitute by the following vote:  Yeas 7, Nays 0; March 16, 2015,
  sent to printer.)
Click here to see the committee vote
 
  COMMITTEE SUBSTITUTE FOR S.B. No. 172 By:  Huffman
 
 
A BILL TO BE ENTITLED
 
AN ACT
 
  relating to the addition of certain substances to Penalty Groups
  1-A and 2 of the Texas Controlled Substances Act for criminal
  prosecution and other purposes.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 481.002(50), Health and Safety Code, is
  amended to read as follows:
               (50)  "Abuse unit" means:
                     (A)  except as provided by Paragraph (B):
                           (i)  a single unit on or in any adulterant,
  dilutant, or similar carrier medium, including marked or perforated
  blotter paper, a tablet, gelatin wafer, sugar cube, or stamp, or
  other medium that contains any amount of a controlled substance
  listed in Penalty Group 1-A, if the unit is commonly used in abuse
  of that substance; or
                           (ii)  each quarter-inch square section of
  paper, if the adulterant, dilutant, or carrier medium is paper not
  marked or perforated into individual abuse units; or
                     (B)  if the controlled substance is in liquid or
  solid form, 40 micrograms of the controlled substance including any
  adulterant or dilutant.
         SECTION 2.  Section 481.1021, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.1021.  PENALTY GROUP 1-A. (a)  Penalty Group 1-A
  consists of:
               (1)  lysergic acid diethylamide (LSD), including its
  salts, isomers, and salts of isomers; and
               (2)  compounds structurally derived from
  2,5-dimethoxyphenethylamine by substitution at the 1-amino
  nitrogen atom with a benzyl substituent, including:
                     (A)  compounds further modified by:
                           (i)  substitution in the phenethylamine ring
  at the 4-position to any extent (including alkyl, alkoxy,
  alkylenedioxy, haloalkyl, or halide substituents); or
                           (ii)  substitution in the benzyl ring to any
  extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
  halide substituents); and
                     (B)  by example, compounds such as:
                           4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)
  phenethylamine (trade or other names: 25B-NBOMe, 2C-B-NBOMe);
                           4-Chloro-2,5-dimethoxy-N-(2-methoxybenzyl)
  phenethylamine (trade or other names: 25C-NBOMe, 2C-C-NBOMe);
                           2,5-Dimethoxy-4-methyl-N-(2-methoxybenzyl)
  phenethylamine (trade or other names: 25D-NBOMe, 2C-D-NBOMe);
                           4-Ethyl-2,5-dimethoxy-N-(2-methoxybenzyl)
  phenethylamine (trade or other names: 25E-NBOMe, 2C-E-NBOMe);
                           2,5-Dimethoxy-N-(2-
  methoxybenzyl)phenethylamine (some trade and other names:
  25H-NBOMe, 2C-H-NBOMe);
                           4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)
  phenethylamine (some trade and other names: 25I-NBOMe,
  2C-I-NBOMe);
                           4-Iodo-2,5-dimethoxy-N-
  benzylphenethylamine (trade or other name: 25I-NB);
                           4-Iodo-2,5-dimethoxy-N-(2,3-
  methylenedioxybenzyl)phenethylamine (trade or other name:
  25I-NBMD);
                           4-Iodo-2,5-dimethoxy-N-(2-
  fluorobenzyl)phenethylamine (trade or other name: 25I-NBF);
                           4-Iodo-2,5-dimethoxy-N-(2-hydroxybenzyl)
  phenethylamine (trade or other name: 25I-NBOH);
                           2,5-Dimethoxy-4-nitro-N-(2-methoxybenzyl)
  phenethylamine (trade or other names: 25N-NBOMe, 2C-N-NBOMe); and
                           2,5-Dimethoxy-4-(n)-propyl-N-(2-
  methoxybenzyl)phenethylamine (some trade and other names:
  25P-NBOMe, 2C-P-NBOMe).
         (b)  To the extent Subsection (a)(2) conflicts with another
  provision of this subtitle or another law, the other provision or
  the other law prevails.
         SECTION 3.  Section 481.103, Health and Safety Code, is
  amended by amending Subsections (a) and (c) and adding Subsection
  (d) to read as follows:
         (a)  Penalty Group 2 consists of:
               (1)  any quantity of the following hallucinogenic
  substances, their salts, isomers, and salts of isomers, unless
  specifically excepted, if the existence of these salts, isomers,
  and salts of isomers is possible within the specific chemical
  designation:
                     5-(2-aminopropyl)benzofuran (5-APB);
                     6-(2-aminopropyl)benzofuran (6-APB);
                     5-(2-aminopropyl)-2,3-dihydrobenzofuran
  (5-APDB);
                     6-(2-aminopropyl)-2,3-dihydrobenzofuran
  (6-APDB);
                     5-(2-aminopropyl)indole (5-IT,5-API);
                     6-(2-aminopropyl)indole (6-IT,6-API);
                     1-(benzofuran-5-yl)-N-methylpropan-2-amine
  (5-MAPB);
                     1-(benzofuran-6-yl)-N-methylpropan-2-amine
  (6-MAPB);
                     Benzothiophenylcyclohexylpiperidine (BTCP);
                     8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
  4-ethanamine (trade or other name: Bromo-DragonFLY);
                     Desoxypipradrol (2-benzhydrylpiperidine);
                     [alpha-ethyltryptamine;
                     [alpha-methyltryptamine;
                     [4-bromo-2, 5-dimethoxyamphetamine (some trade or
  other names:     4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
  4-bromo-2, 5-DMA);
                     [4-bromo-2, 5-dimethoxyphenethylamine;
                     [Bufotenine (some trade and other
  names:     3-(beta- Dimethylaminoethyl)-5-hydroxyindole;
  3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
  5-hydroxy-N, N- dimethyltryptamine; mappine);
                     [Diethyltryptamine (some trade and other
  names:     N, N-Diethyltryptamine, DET);]
                     2, 5-dimethoxyamphetamine (some trade or other
  names:  2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
                     Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
  methanol, D2PM);
                     [2, 5-dimethoxy-4-ethylamphetamine (trade or
  other name:     DOET);
                     [2, 5-dimethoxy-4-(n)-propylthiophenethylamine
  (trade or other name:     2C-T-7);
                     [Dimethyltryptamine (trade or other name:  DMT);]
                     Dronabinol (synthetic) in sesame oil and
  encapsulated in a soft gelatin capsule in a U.S. Food and Drug
  Administration approved drug product (some trade or other names for
  Dronabinol:  (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
  trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
  (trans)- tetrahydrocannabinol);
                     Ethylamine Analog of Phencyclidine (some trade or
  other names:  N-ethyl-1-phenylcyclohexylamine, (1-
  phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
  cyclohexamine, PCE);
                     2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
  (trade or other name: methoxetamine);
                     Ibogaine (some trade or other names:  7-Ethyl-6,
  6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
  pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
                     5-iodo-2-aminoindane (5-IAI);
                     Mescaline;
                     [5-methoxy-N, N-diisopropyltryptamine;]
                     5-methoxy-3, 4-methylenedioxy amphetamine;
                     4-methoxyamphetamine (some trade or other
  names:  4-methoxy-alpha-methylphenethylamine;
  paramethoxyamphetamine; PMA);
                     4-methoxymethamphetamine (PMMA);
                     2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
  (some trade and other names: 2-MeO-ketamine; methoxyketamine);
                     1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
  PPMP);
                     4-methyl-2, 5-dimethoxyamphetamine (some trade
  and other names:  4-methyl-2, 5-dimethoxy-alpha-
  methylphenethylamine; "DOM"; "STP");
                     3,4-methylenedioxy methamphetamine (MDMA, MDM);
                     3,4-methylenedioxy amphetamine;
                     3,4-methylenedioxy N-ethylamphetamine (Also
  known as N-ethyl MDA);
                     5,6-methylenedioxy-2-aminoindane (MDAI);
                     Nabilone (Another name for nabilone:  (+)-trans-
  3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
  6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
                     N-benzylpiperazine (some trade or other
  names:  BZP; 1-benzylpiperazine);
                     N-ethyl-3-piperidyl benzilate;
                     N-hydroxy-3,4-methylenedioxyamphetamine (Also
  known as N-hydroxy MDA);
                     4-methylaminorex;
                     N-methyl-3-piperidyl benzilate;
                     Parahexyl (some trade or other names:  3-Hexyl-1-
  hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
  pyran; Synhexyl);
                     1-Phenylcyclohexylamine;
                     1-Piperidinocyclohexanecarbonitrile (PCC);
                     [Psilocin;
                     [Psilocybin;]
                     Pyrrolidine Analog of Phencyclidine (some trade
  or other names:  1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
                     Tetrahydrocannabinols, other than marihuana, and
  synthetic equivalents of the substances contained in the plant, or
  in the resinous extractives of Cannabis, or synthetic substances,
  derivatives, and their isomers with similar chemical structure and
  pharmacological activity such as:
                           delta-1 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           delta-6 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           delta-3, 4 cis or trans
  tetrahydrocannabinol, and its optical isomers; or
                           compounds of these structures, regardless of
  numerical designation of atomic positions, since nomenclature of
  these substances is not internationally standardized;
                     Thiophene Analog of Phencyclidine (some trade or
  other names:  1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
  Analog of Phencyclidine; TPCP, TCP);
                     1-pyrrolidine (some trade or other name:  TCPy);
                     1-(3-trifluoromethylphenyl)piperazine (trade or
  other name:  TFMPP); and
                     3,4,5-trimethoxy amphetamine;
               (2)  Phenylacetone (some trade or other
  names:  Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
  ketone);
               (3)  unless specifically excepted or unless listed in
  another Penalty Group, a material, compound, mixture, or
  preparation that contains any quantity of the following substances
  having a potential for abuse associated with a depressant or
  stimulant effect on the central nervous system:
                     Aminorex (some trade or other
  names:  aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
  phenyl-2-oxazolamine);
                     Amphetamine, its salts, optical isomers, and
  salts of optical isomers;
                     Cathinone (some trade or other names:  2-amino-1-
  phenyl-1-propanone, alpha-aminopropiophenone, 2-
  aminopropiophenone);
                     Etaqualone and its salts;
                     Etorphine Hydrochloride;
                     Fenethylline and its salts;
                     Lisdexamfetamine, including its salts, isomers,
  and salts of isomers;
                     Mecloqualone and its salts;
                     Methaqualone and its salts;
                     Methcathinone (some trade or other names:  2-
  methylamino-propiophenone; alpha-(methylamino)propriophenone;
  2-(methylamino)-1-phenylpropan-1-one; alpha-N-
  methylaminopropriophenone; monomethylpropion; ephedrone, N-
  methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
  1431);
                     N-Ethylamphetamine, its salts, optical isomers,
  and salts of optical isomers; and
                     N,N-dimethylamphetamine (some trade or other
  names: N,N,alpha-trimethylbenzeneethanamine 
  [N,N,alpha-trimethylbenzeneethaneamine];
  N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
  and salts of optical isomers; [and]
               (4)  any compound structurally derived from
  2-aminopropanal by substitution at the 1-position with any
  monocyclic or fused-polycyclic ring system, including:
                     (A)  compounds further modified by:
                           (i)  substitution in the ring system to any
  extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
  halide substituents), whether or not further substituted in the
  ring system by other substituents;
                           (ii)  substitution at the 3-position with an
  alkyl substituent; or
                           (iii)  substitution at the 2-amino nitrogen
  atom with alkyl, benzyl, [or] dialkyl, or methoxybenzyl groups, or
  inclusion of the 2-amino nitrogen atom in a cyclic structure; and
                     (B)  by example, compounds such as:
                           4-Methylmethcathinone (Also known as
  Mephedrone);
                           3,4-Dimethylmethcathinone (Also known as
  3,4-DMMC);
                           3-Fluoromethcathinone (Also known as 3-FMC);
                           4-Fluoromethcathinone (Also known as
  Flephedrone);
                           3,4-Methylenedioxy-N-methylcathinone (Also
  known as Methylone);
                           3,4-Methylenedioxypyrovalerone (Also known
  as MDPV);
                           alpha-Pyrrolidinopentiophenone (Also known
  as alpha-PVP);
                           Naphthylpyrovalerone  (Also known as
  Naphyrone);
                           alpha-Methylamino-valerophenone (Also known
  as Pentedrone);
                           beta-Keto-N-methylbenzodioxolylpropylamine
  (Also known as Butylone);
                           beta-Keto-N-methylbenzodioxolylpentanamine
  (Also known as Pentylone);
                           beta-Keto-Ethylbenzodioxolylbutanamine
  (Also known as Eutylone); and
                           3,4-methylenedioxy-N-ethylcathinone (Also
  known as Ethylone);
               (5)  any compound structurally derived from tryptamine
  (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
                     (A)  by modification in any of the following ways:
                           (i)  by substitution at the amine nitrogen
  atom of the sidechain to any extent with alkyl or alkenyl groups or
  by inclusion of the amine nitrogen atom of the side chain (and no
  other atoms of the side chain) in a cyclic structure;
                           (ii)  by substitution at the carbon atom
  adjacent to the nitrogen atom of the side chain (alpha-position)
  with an alkyl or alkenyl group;
                           (iii)  by substitution in the 6-membered
  ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,
  alkylenedioxy, or halide substituents; or
                           (iv)  by substitution at the 2-position of
  the tryptamine ring system with an alkyl substituent; and
                     (B)  including:
                           (i)  ethers and esters of the controlled
  substances listed in this subdivision; and
                           (ii)  by example, compounds such as:
                                 alpha-ethyltryptamine;
                                 alpha-methyltryptamine;
                                 Bufotenine (some trade and other names:
  3-(beta-Dimethylaminoethyl)-5-hydroxyindole;
  3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
  5-hydroxy-N, N- dimethyltryptamine; mappine);
                                 Diethyltryptamine (some trade and
  other names: N, N-Diethyltryptamine, DET);
                                 Dimethyltryptamine (trade or other
  name: DMT);
                                 5-methoxy-N, N-diisopropyltryptamine
  (5-MeO-DiPT);
                                 O-Acetylpsilocin (Trade or other name:
  4-Aco-DMT);
                                 Psilocin; and
                                 Psilocybin;
               (6)  2,5-Dimethoxyphenethylamine and any compound
  structurally derived from 2,5-Dimethoxyphenethylamine by
  substitution at the 4-position of the phenyl ring to any extent
  (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide
  substituents), including, by example, compounds such as:
                     4-Bromo-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-B);
                     4-Chloro-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-C);
                     2,5-Dimethoxy-4-methylphenethylamine (trade or
  other name: 2C-D);
                     4-Ethyl-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-E);
                     4-Iodo-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-I);
                     2,5-Dimethoxy-4-nitrophenethylamine (trade or
  other name: 2C-N);
                     2,5-Dimethoxy-4-(n)-propylphenethylamine (trade
  or other name: 2C-P);
                     4-Ethylthio-2,5-dimethoxyphenethylamine (trade
  or other name: 2C-T-2);
                     4-Isopropylthio-2,5-dimethoxyphenethylamine
  (trade or other name: 2C-T-4); and
                     2,5-Dimethoxy-4-(n)-propylthiophenethylamine
  (trade or other name: 2C-T-7); and
               (7)  2,5-Dimethoxyamphetamine and any compound
  structurally derived from 2,5-Dimethoxyamphetamine by substitution
  at the 4-position of the phenyl ring to any extent (including alkyl,
  alkoxy, alkylenedioxy, haloalkyl, or halide substituents),
  including, by example, compounds such as:
                     4-Ethylthio-2,5-dimethoxyamphetamine (trade or
  other name: Aleph-2);
                     4-Isopropylthio-2,5-dimethoxyamphetamine (trade
  or other name: Aleph-4);
                     4-Bromo-2,5-dimethoxyamphetamine (trade or other
  name: DOB);
                     4-Chloro-2,5-dimethoxyamphetamine (trade or
  other name: DOC);
                     2,5-Dimethoxy-4-ethylamphetamine (trade or other
  name: DOET);
                     4-Iodo-2,5-dimethoxyamphetamine (trade or other
  name: DOI);
                     2,5-Dimethoxy-4-methylamphetamine (trade or
  other name: DOM);
                     2,5-Dimethoxy-4-nitroamphetamine (trade or other
  name: DON);
                     4-Isopropyl-2,5-dimethoxyamphetamine (trade or
  other name: DOIP); and
                     2,5-Dimethoxy-4-(n)-propylamphetamine (trade or
  other name: DOPR).
         (c)  To the extent Subsection (a)(4), (5), (6), or (7)
  conflicts with another provision or this subtitle or another law,
  the other provision [subtitle] or the other law prevails. If a
  substance listed in this section is also listed in another penalty
  group, the listing in the other penalty group controls.
         (d)  If a substance listed in this section is approved by the
  Federal Drug Administration, the inclusion of that substance in
  this penalty group does not apply, and notwithstanding any other
  law, a person may not be convicted for the manufacture or delivery
  of the substance under Section 481.113 or for possession of the
  substance under Section 481.116.
         SECTION 4.  The change in law made by this Act applies only
  to an offense committed on or after the effective date of this Act.
  An offense committed before the effective date of this Act is
  governed by the law in effect on the date the offense was committed,
  and the former law is continued in effect for that purpose. For
  purposes of this section, an offense was committed before the
  effective date of this Act if any element of the offense occurred
  before that date.
         SECTION 5.  This Act takes effect September 1, 2015.
 
  * * * * *